|
|
| Biowin Pharma (India) Limited |
|
Financials-Biowin Pharma (India) Limited| Sector: Formulations | | BSE:31372 | NSE:NA | Bloomberg:BWPI@IN | Reuters:NA | | Market Lot: | Face Value: 10 | ISIN Demat: INE244D01010 |
|
|
| |
| Financials (Standalone) |
|
|
|
|
../financials/latestHalf.php
| Latest Quarterly/Halfyearly |
|
| As On(Months) |
31-Mar-2002(3) |
31-Mar-2001(3) |
% Change |
| Sales of Products/Services |
142.81 |
65.73 |
117.27 |
| Other Operating Income |
0.00 |
0.00 |
-- |
| Other Income |
2.35 |
11.53 |
-79.62 |
| Total Income |
145.16 |
77.26 |
87.89 |
| Total Expenses |
144.21 |
73.00 |
97.55 |
| OPBDIT |
0.95 |
4.26 |
-77.70 |
| Interest |
0.00 |
1.96 |
-- |
| Depreciation |
0.35 |
0.35 |
0.00 |
| Exceptional & Extraordinary Items |
0.00 |
0.00 |
-- |
| Prior Period Adjustments |
0.00 |
0.00 |
-- |
| Provision for Tax |
0.00 |
0.00 |
-- |
| After Tax Profit |
0.60 |
1.95 |
-69.23 |
| Equity Capital |
50.50 |
50.51 |
-0.02 |
| Reserves |
0.00 |
0.00 |
-- |
| Notes to Accounts |
Click here |
Click here |
|
|
| As on( Months ) |
31-Mar-99(12) |
|
31-Mar-98(12) |
|
31-Mar-97(12) |
|
| Profit / Loss A/C |
Rs mn |
%OI |
Rs mn |
%OI |
Rs mn |
%OI |
| Net Sales |
197.73 |
97.42 |
166.71 |
96.82 |
154.48 |
97.88 |
| Operating Income (OI) |
202.96 |
100.00 |
172.19 |
100.00 |
157.82 |
100.00 |
| OPBDIT |
12.89 |
6.35 |
10.64 |
6.18 |
9.81 |
6.22 |
| OPBDT |
4.57 |
2.25 |
3.99 |
2.32 |
5.74 |
3.64 |
| OPBT |
2.56 |
1.26 |
2.35 |
1.36 |
4.45 |
2.82 |
| Non-Operating Income |
1.28 |
0.63 |
0.61 |
0.35 |
0.30 |
0.19 |
| Extraordinary/Prior Period |
-0.07 |
-0.03 |
-0.26 |
-0.15 |
0.00 |
0.00 |
| Tax |
0.40 |
0.20 |
0.31 |
0.18 |
0.61 |
0.39 |
| Profit after tax(PAT) |
3.36 |
1.66 |
2.39 |
1.39 |
4.13 |
2.62 |
| Cash Profit |
5.38 |
2.65 |
4.03 |
2.34 |
5.43 |
3.44 |
| Dividend-Equity |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| As on |
31-Mar-99 |
|
31-Mar-98 |
|
31-Mar-97 |
|
| Assets |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Gross Block |
32.02 |
23.54 |
29.86 |
22.74 |
23.17 |
23.60 |
| Net Block |
30.52 |
22.44 |
28.73 |
21.88 |
21.83 |
22.24 |
| Capital WIP |
1.70 |
1.25 |
8.05 |
6.13 |
6.82 |
6.94 |
| Investments |
0.05 |
0.04 |
0.05 |
0.04 |
0.05 |
0.05 |
| Inventory |
33.61 |
24.71 |
31.15 |
23.72 |
26.28 |
26.78 |
| Receivables |
58.24 |
42.82 |
53.03 |
40.38 |
37.60 |
38.31 |
| Other Current Assets |
11.91 |
8.76 |
10.31 |
7.85 |
5.57 |
5.68 |
| Balance Sheet Total(BT) |
136.03 |
100.00 |
131.32 |
100.00 |
98.15 |
100.00 |
| Liabilities |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Equity Share Capital |
50.51 |
37.13 |
50.51 |
38.46 |
50.51 |
51.46 |
| Reserves |
12.69 |
9.33 |
8.82 |
6.71 |
5.91 |
6.03 |
| Total Debt |
48.63 |
35.75 |
43.31 |
32.98 |
24.18 |
24.64 |
| Creditors and Acceptances |
19.84 |
14.58 |
22.85 |
17.40 |
12.94 |
13.19 |
| Other current liab/prov. |
4.36 |
3.21 |
5.84 |
4.45 |
4.61 |
4.69 |
| Balance Sheet Total(BT) |
136.03 |
100.00 |
131.32 |
100.00 |
98.15 |
100.00 |
|
| As on |
31-Mar-99 |
31-Mar-98 |
31-Mar-97 |
| OPBIT/Prod.cap.empl.(%) |
9.88 |
9.52 |
11.55 |
| PBIT/Cap. Employed (%) |
10.97 |
9.88 |
11.95 |
| PAT/Networth (%) |
5.32 |
4.02 |
7.32 |
| Tax/PBT (%) |
10.72 |
11.50 |
12.90 |
| Total Debt/Networth (x) |
0.77 |
0.73 |
0.43 |
| Long Term Debt/Networth (x) |
0.16 |
0.19 |
0.21 |
| PBDIT/Finance Charges (x) |
1.70 |
1.65 |
2.48 |
| Current Ratio (x) |
4.29 |
3.29 |
3.96 |
| RM Inventory (days consumption) |
29.99 |
432.35 |
286.90 |
| FG inventory (days cost of sales) |
35.08 |
38.97 |
36.07 |
| Receivables (days gross sales) |
107.51 |
116.10 |
88.78 |
| Creditors (days cost of sales) |
38.10 |
51.62 |
31.92 |
| Op. curr. assets (days OI) |
187.00 |
200.00 |
161.00 |
|
|
Financials